Does Prednisone Help Vertigo? How It Works & When to Use It

Prednisone can reduce vertigo in certain conditions, but its usefulness depends entirely on what is causing the dizziness. The strongest evidence supports its use in vestibular neuritis, where a landmark trial showed that corticosteroids roughly doubled the recovery of inner-ear function compared with placebo. For other common causes of vertigo, such as benign positional vertigo or Ménière’s disease, the picture is far murkier. The drug is not a general-purpose fix for dizziness, and using it without the right diagnosis can mean enduring side effects for nothing.

How Prednisone Acts Inside the Inner Ear

Prednisone is a synthetic glucocorticoid, a class of steroid that mimics cortisol. In most of the body it works by suppressing inflammation, but its behavior in the ear is more specific. The inner ear has a high concentration of both mineralocorticoid and glucocorticoid receptors. When prednisone (or its close relative methylprednisolone) binds to the glucocorticoid receptor there, it triggers anti-inflammatory and cell-survival signals that protect the delicate sensory structures from further damage.¹ That dual action, calming inflammation while reducing nerve-cell death, is why steroids are prescribed after sudden vestibular injury rather than simply to mask symptoms.

Vestibular Neuritis and the Best Available Evidence

Vestibular neuritis is an inflammation of the vestibular nerve, usually assumed to be triggered by a viral infection. It causes sudden, severe, rotational vertigo that can last days to weeks. This is the condition where prednisone has been studied most carefully, and the headline result comes from a randomized trial published in the New England Journal of Medicine. In that study, patients who received methylprednisolone saw their peripheral vestibular function improve by about 62 percentage points over 12 months, compared with roughly 40 percentage points for those on placebo. Adding the antiviral valacyclovir on top of the steroid made no additional difference.²

A separate trial found that prednisone-treated patients showed faster normalization on caloric testing at the one- and three-month marks, with higher rates of complete resolution at three and six months, though symptom scores and self-reported dizziness handicap were similar between groups by the end of the study.³ That pattern, faster objective improvement on lab testing but less dramatic differences in how patients feel, shows up repeatedly in this literature. The Cochrane systematic review of corticosteroids for vestibular neuritis found a significant benefit for complete caloric recovery at one month (patients were about three times as likely to recover fully) but no significant effect at 12 months, and no meaningful difference on self-reported dizziness at any time point.⁴

Taken together, the evidence suggests steroids speed up vestibular recovery from neuritis in a measurable way, but by the time a year has passed, the gap between treated and untreated patients narrows. Whether that early acceleration matters to you depends on how severe the acute episode is and how quickly you need to get back to daily life.

Why Timing Changes Everything

If steroids do help in vestibular neuritis, the window for starting them appears to be narrow. A study tracking patients treated at different intervals after symptom onset found that every single patient who received steroids within the first 24 hours had a normal caloric test at three months, compared with just under 60 percent of those treated between 25 and 72 hours after onset.⁵ That is a striking gap, though the study was small. Still, the general direction of the finding aligns with what we know about inflammation: once nerve damage has set in, suppressing the inflammatory process that already did its work offers diminishing returns.

In practice, this means that if you show up at urgent care three or four days into an episode, the benefit of starting steroids is much less certain than if you had been treated on day one. Clinicians who prescribe steroids for vestibular neuritis often try to start treatment as soon as possible, ideally within the first 72 hours and preferably within the first day.

Short-Term Gains, Similar Long-Term Outcomes

One finding that comes up consistently is that steroids may accelerate recovery without necessarily changing where you end up a year later. A study comparing corticosteroids, vestibular rehabilitation therapy, and the combination of both found no statistically significant difference among the three groups at the end of follow-up.⁶ The conclusion was that corticosteroids may accelerate recovery but offer no extra benefit for the long-term prognosis of the disease. A recent double-blind, placebo-controlled trial reinforced this view, reporting no significant differences in secondary outcomes between the steroid and placebo groups.⁷

There is, however, a meaningful short-term story. One study found that patients given glucocorticoids had substantially lower dizziness handicap scores at discharge and shorter hospital stays, averaging about two days versus nearly four days for the untreated group.⁸ For someone who is vomiting, unable to stand, and miserable in a hospital bed, shaving a couple of days off that phase is not trivial, even if it doesn’t change the 12-month picture.

Ménière’s Disease

Ménière’s disease involves episodic vertigo, hearing loss, tinnitus, and a feeling of fullness in the ear. It has an entirely different mechanism from vestibular neuritis, thought to involve abnormal fluid pressure in the inner ear. The role of steroids here is less clear. A pilot study found that oral prednisone reduced the frequency of vertigo episodes by about half and their duration by roughly a third in patients whose vertigo had resisted other treatments. Tinnitus also improved, though hearing and aural fullness did not change.⁹ Those results are encouraging but preliminary, and a broad review of steroid use in otolaryngology described the evidence for steroids in Ménière’s disease as “controversial.”¹⁰

In clinical practice, some physicians use short steroid courses during severe Ménière’s flares, particularly when standard approaches like salt restriction and diuretics have failed. But long-term steroid use for a chronic, episodic condition like Ménière’s raises real concerns about side effects, including blood-sugar spikes, bone thinning, weight gain, and immune suppression. Intratympanic steroid injections delivered directly into the middle ear offer a way to get the drug to the inner ear with fewer systemic effects, and this route is increasingly popular for refractory Ménière’s cases, though for sudden hearing loss the two delivery methods appear roughly equal in effectiveness.¹¹

When Prednisone Will Not Help at All

The most common cause of vertigo in the general population is benign paroxysmal positional vertigo, or BPPV. This happens when tiny calcium crystals in the inner ear drift into the wrong canal, triggering brief, intense spinning when you move your head in certain ways. There is no inflammation for steroids to treat. The standard fix is a repositioning maneuver performed by a clinician, which resolves the problem in over 95 percent of cases, though recurrence over time is common.¹² Prescribing prednisone for BPPV is a waste of time and carries needless risk.

Similarly, vertigo caused by a posterior circulation stroke, a blood-clot or bleed in the brain’s balance centers, is a medical emergency requiring entirely different treatment. The danger here is misdiagnosis: a stroke can initially look a lot like vestibular neuritis. This is where the bedside HINTS exam becomes critical. A three-step eye-movement test (checking the vestibulo-ocular reflex, looking for direction-changing nystagmus, and testing for vertical eye misalignment) was found in one study to be 100 percent sensitive and 96 percent specific for identifying stroke in patients presenting with sudden vertigo.¹³ Starting someone on steroids when they are actually having a stroke delays the treatment they need.

Autoimmune Inner Ear Disease

One condition where steroids are not just helpful but are considered the cornerstone of treatment is autoimmune inner ear disease, or AIED. This rare disorder involves the immune system attacking the inner ear, causing progressive hearing loss and, in a subset of patients, vestibular symptoms like vertigo and disequilibrium.¹⁴ Response to corticosteroids is actually part of how AIED is diagnosed: if your hearing improves on a high-dose steroid course, that supports the autoimmune theory. Unlike sudden hearing loss, where there is a narrow treatment window of just a few weeks, AIED appears to remain steroid-responsive for a longer period of weeks to months.¹⁵

The problem is that AIED tends to be chronic, and keeping someone on high-dose prednisone indefinitely is not sustainable. Researchers have explored steroid-sparing agents such as methotrexate, though a randomized controlled trial found that methotrexate did not outperform placebo for hearing improvement in AIED patients, despite its widespread use.¹⁶ Finding a safe long-term alternative to prednisone remains an open challenge for this patient group.

Vestibular Rehabilitation as a Complement or Alternative

Vestibular rehabilitation therapy, or VRT, consists of structured exercises designed to retrain the brain’s balance system after inner-ear damage. A systematic review and meta-analysis comparing VRT with corticosteroid treatment for vestibular neuritis found that patients in the VRT group had significantly lower dizziness handicap scores at one month than those on corticosteroids alone. When the two treatments were combined, dizziness handicap scores were even better at three months than with steroids alone.¹⁷

This is worth knowing because VRT has essentially no side effects. If the long-term outcomes of steroids and VRT are comparable, as the evidence suggests, then the practical question for many patients is less “should I take prednisone?” and more “how quickly do I need to feel better, and what am I willing to tolerate?” For someone in the acute crisis phase of vestibular neuritis, a short steroid course can blunt the worst of the symptoms and get them to a point where they can begin exercises. After that, VRT appears to do the heavy lifting for sustained recovery.

Oral Versus Intratympanic Steroids

Prednisone is the oral formulation most commonly prescribed, while methylprednisolone and dexamethasone are sometimes delivered directly through the eardrum via injection. This intratympanic route has the advantage of getting a concentrated dose straight to the inner ear while minimizing the systemic exposure that causes side effects like insomnia, mood swings, and elevated blood sugar. A randomized trial comparing oral prednisone with intratympanic methylprednisolone for sudden sensorineural hearing loss found the two approaches produced nearly identical hearing recovery at two months.¹⁸ A later meta-analysis confirmed no significant difference in effectiveness between the two routes.¹¹

Most of those studies focused on hearing outcomes, not vertigo specifically, so the results do not translate one-to-one. But the principle is relevant: if you are someone who tolerates oral prednisone poorly, or who has diabetes or another condition where systemic steroids are especially risky, an intratympanic injection may offer a similar benefit to the inner ear with fewer trade-offs elsewhere in the body. The injection is done in-office, is mildly uncomfortable, and sometimes needs to be repeated.

Children with Vestibular Neuritis

Vertigo in children is under-recognized and under-studied. Vestibular neuritis in pediatric patients tends to follow a similar course to the adult version, with acute rotational vertigo that gradually resolves. One study examining clinical features and recovery in children and adolescents with vestibular neuritis noted that only two patients in the series received oral steroids, and neither had an incomplete recovery, but the sample was far too small to draw conclusions about whether steroids helped.¹⁹ There are no pediatric randomized controlled trials of steroids for vestibular neuritis. Clinicians treating children with this condition are essentially extrapolating from adult data, which is common in pediatric medicine but worth being aware of if you are a parent seeking answers.

Recurrence After Recovery

Most people who recover from vestibular neuritis stay recovered. The recurrence rate has been estimated at somewhere between 2 and 12 percent.¹² That is reassuringly low, though it does mean a small fraction of patients will experience a second episode, sometimes in the opposite ear. Whether initial steroid treatment reduces or has no effect on recurrence risk is not clearly established. If you do experience a recurrence, the same treatment principles apply: early steroid treatment if inflammation is suspected, and vestibular rehabilitation for long-term balance recovery.

Compare that with BPPV, where the long-term recurrence rate is around 50 percent despite the high success rate of repositioning maneuvers. Or Ménière’s disease, which is chronic and episodic by nature. The type of vertigo you have determines not just whether prednisone will help in the moment, but what your trajectory looks like over the following months and years.

1
PubMed Central. Corticosteroid therapy for hearing and balance disorders
2
PubMed. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis
3
Otology & Neurotology. Prednisone Treatment for Vestibular Neuritis
4
Cochrane Database of Systematic Reviews. Corticosteroids for the management of idiopathic acute vestibular dysfunction (vestibular neuritis)
5
PubMed Central. Steroids for Acute Vestibular Neuronitis—the Earlier the Treatment, the Better the Outcome?
6
PubMed Central. Corticosteroids versus vestibular rehabilitation in long-term outcomes in vestibular neuritis
7
PubMed Central. Acute unilateral vestibulopathy and corticosteroid treatment – A randomized placebo-controlled double-blind trial
8
PubMed. Glucocorticoids improve acute dizziness symptoms following acute unilateral vestibulopathy
9
PubMed. Oral administration of prednisone to control refractory vertigo in Ménière’s disease: a pilot study
10
PubMed. Steroids in otolaryngology
11
PubMed Central. Intratympanic Versus Systemic Steroid Therapy for Idiopathic Sudden Hearing Loss: A Systematic Review and Meta-Analysis
12
PubMed Central. The treatment and natural course of peripheral and central vertigo
13
PubMed Central. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging
14
PubMed Central. Immunosuppressive therapy for autoimmune inner ear disease
15
The Journal of Clinical Investigation. IL-1β inhibition in autoimmune inner ear disease: can you hear me now?
16
JAMA. Treatment of Corticosteroid-Responsive Autoimmune Inner Ear Disease With Methotrexate: A Randomized Controlled Trial
17
PubMed Central. Vestibular Rehabilitation Therapy and Corticosteroids for Vestibular Neuritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
18
JAMA. Oral vs Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Trial
19
PubMed. Vestibular neuritis in children and adolescents: Clinical features and recovery